Kristian Reich Insider Trades & Stock Holdings

Chief Scientific Officer · MoonLake Immunotherapeutics · Latest filing Jun 17, 2026

Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics has 2 Form 4 trades on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($1.91M), net -$1.91M. Latest filing: disposed of 50K shares of $MLTX on Jun 17, 2026 at $19.43.

Trades on file

2

Open-market bought

$0

Open-market sold

$1.91M

Net open-market

-$1.91M

Latest filing

Jun 17, 2026

All insider trades by Kristian Reich

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 17, 2026	$MLTX	Sell (Open-market sale) 10b5-1	50K	$19.43	$971.50K			+4.2%	+2.6%		Chief Scientific Officer		—
Jun 16, 2026	$MLTX	Sell (Open-market sale) 10b5-1	50K	$18.70	$935K			+11.8%	+0.2%		Chief Scientific Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kristian Reich traded

• $MLTX

Frequently asked questions

Has Kristian Reich been buying or selling stock?

Kristian Reich has 0 open-market purchases and 2 open-market sales on file, net -$1.91M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kristian Reich's latest insider trade?

disposed of 50K shares of $MLTX on Jun 17, 2026 at $19.43.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.